Jeppson Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$242K Buy
+4,762
New +$222K 0.08% 199
2024
Q3
Sell
-2,248
Closed -$267K 209
2024
Q2
$267K Sell
2,248
-27
-1% -$3.42K 0.1% 163
2024
Q1
$242K Sell
2,275
-21
-0.9% -$2.12K 0.09% 177
2023
Q4
$228K Buy
+2,296
New +$193K 0.09% 176
2023
Q2
Sell
-1,307
Closed -$201K 200
2023
Q1
$201K Sell
1,307
-17
-1% -$2.8K 0.09% 188
2022
Q4
$238K Buy
+1,324
New +$216K 0.1% 178
2020
Q4
Sell
-467
Closed -$33K 329
2020
Q3
$33K Buy
+467
New +$32.6K 0.03% 268

Other funds holding MRNA

Jeppson Wealth Management's MRNA Position: Q1 2026 in Review

Jeppson Wealth Management opened a new position in Moderna (MRNA) in Q1 2026: 4,762 shares worth $242K. The stake represents 0.08% of the portfolio and ranks #199 among its holdings. This is a return to the name: Jeppson Wealth Management previously reported a position in MRNA as recently as Q2 2024.

Jeppson Wealth Management first reported a position in MRNA in Q3 2020 and has held it in 7 quarters since. The position peaked at $267K in Q2 2024. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Jeppson Wealth Management held 4,762 shares of Moderna worth $242K as of Q1 2026.
  • Moderna was a new Jeppson Wealth Management position in Q1 2026.
  • Moderna made up 0.08% of Jeppson Wealth Management's portfolio in Q1 2026, its #199 holding.
  • Jeppson Wealth Management first reported a position in Moderna in Q3 2020 and has held it in 7 quarters since.
  • Jeppson Wealth Management's Moderna position peaked at $267K in Q2 2024.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Jeppson Wealth Management's 13F filing for Q1 2026, filed 14 Apr 2026.